Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
26.90
0.00 (0.00%)
Jun 18, 2026, 4:08 PM HKT

HKG:3378 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-131.01-115.83-76.06
Depreciation & Amortization
6.265.371.01
Other Amortization
0.140.110.03
Loss (Gain) From Sale of Investments
-13.98-1.6233.1
Stock-Based Compensation
20.9222.3515.49
Other Operating Activities
-0.34-7.28-20.62
Change in Accounts Payable
18.637.780.88
Change in Other Net Operating Assets
-2.99-15.77-5.83
Operating Cash Flow
-102.38-104.89-51.99
Capital Expenditures
-1.84-6.21-4.23
Sale (Purchase) of Intangibles
-0.1--0.55
Investment in Securities
34.799.9194.63
Other Investing Activities
0.362.924.11
Investing Cash Flow
33.1196.6293.96
Long-Term Debt Issued
67--
Long-Term Debt Repaid
-23.91-3.81-1.16
Net Debt Issued (Repaid)
43.09-3.81-1.16
Issuance of Common Stock
516.6212.8491.38
Other Financing Activities
-34.84-2.55-
Financing Cash Flow
524.876.4990.22
Foreign Exchange Rate Adjustments
-2.4110.03
Net Cash Flow
453.19-0.79132.21
Free Cash Flow
-104.22-111.1-56.23
Free Cash Flow Margin
-113280.44%-5052.48%-2214.49%
Free Cash Flow Per Share
-0.88-0.94-7.71
Cash Interest Paid
0.85--
Cash Income Tax Paid
-5.812.05
Levered Free Cash Flow
-176.03101.65-
Unlevered Free Cash Flow
-168.77107.51-
Change in Working Capital
15.64-7.99-4.95